Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1981 May;26(5):438-43.
doi: 10.1007/BF01313587.

Mesenteric vascular reactivity to histamine receptor agonists and antagonists

Mesenteric vascular reactivity to histamine receptor agonists and antagonists

K M Walus et al. Dig Dis Sci. 1981 May.

Abstract

Response patterns of intestinal blood flow, oxygen extraction and consumption, blood flow distribution, and motility were assessed during intraarterial infusions of histamine, histamine after H1 or H2 blockade, dimaprit or dimaprit after H2 blockade. Histamine produced an initial peak response of blood flow with a slow decrease thereafter. Oxygen extraction was evenly depressed throughout the infusion, and oxygen consumption increased at the beginning. All initial responses were blocked by tripelennamine. Ranitidine, a new H2 antagonist, accelerated the decay of all responses. Dimaprit produced effects identical to those of histamine after tripelennamine. Distribution of blood flow was unchanged at the beginning of histamine infusion, but subsequently showed a shift to muscularis which was blocked by tripelennamine. Histamine usually stimulated intestinal contractions and this effect was abolished by tripelennamine. Thus, H1 stimulation, besides producing an initial vasodilation, increases oxygen uptake and redistributes flow to the muscularis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Br J Pharmacol. 1979 Jul;66(3):464P - PubMed
    1. Circ Shock. 1979;6(3):213-21 - PubMed
    1. Am J Physiol. 1977 Apr;232(4):H437-40 - PubMed
    1. Br J Pharmacol. 1974 Dec;52(4):481-98 - PubMed
    1. Br J Pharmacol. 1977 Jun;60(2):173-80 - PubMed

Publication types

MeSH terms